Published
2025-01-14
Section
Articles
How to Cite
RIG-I 在糖尿病视网膜病变中的表达及其与炎症反应的相关性研究
李 慧
南昌职业大学
贺 鹤平
南昌职业大学
DOI: https://doi.org/10.59429/xjjz.v6i4.8644
Keywords: 糖尿病视网膜病变；RIG-I；炎症反应；Müller 细胞；NF-κB 信号通路
Abstract
本研究探讨了 RIG-I 在糖尿病视网膜病变（DR）中的表达及其与炎症反应的相关性。研究发现，RIG-I 在 增生性糖尿病性视网膜病变（PDR）患者的玻璃体中表达增加，并且在糖尿病大鼠模型中，随着糖尿病病程的延长， RIG-I 在视网膜组织中的表达也显著增加。这些结果表明 RIG-I 与 DR 有明显的相关性。研究还推测 RIG-I 可能在 Müller 细胞中表达增加，并作为 NF-κB 信号的正调节剂参与糖尿病视网膜病变中的炎症反应。本研究为理解 RIG-I 在糖尿病视网膜病变中的作用提供了新的视角，并为未来的治疗策略提供了潜在的靶点。
References
[1] Klein B E. Overview of epidemiologic studies of diabetic retinopathy[J]. Ophthalmic Epidemiol,2007(14):179-183.
[2] Zhang X, Saaddine J B, Chou C F, et al. Prevalence of diabetic retinopathy in the United States[J]. JAMA,2010(304):649-656.
[3] Sun J K, Lin M M, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema[J]. JAMA Ophthalmol, 2014(132):1309-1316.
[4] Jialal I, Kaur H. The role of toll-like receptors in diabetes-induced inflammation: Implications for vascular complications[J]. Curr Diabetes Rep,2012(12):172-179.
[5] Serhan C N, Brain S D, Buckley C D, et al. Resolution of inflammation: State of the art, definitions and terms[J]. FASEB J,2007(21):325-332.
[6] Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses[J]. Nat Immunol,2004,5(7):730-7.
[7] Seth RB, Sun L, Ea CK, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3[J]. Cell,2005,122(5):669-82.
[8] Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity[J]. J Immunol,2005,175(5):2851-8.
[9] Saito T, Hirai R, Loo YM, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2[J]. Proc Natl Acad Sci U S A,2007,104(2):582-7.
[10] Kowalinski E, Lunardi T, McCarthy AA, et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA[J]. Cell,2011,147(2):423-35.
[11] Zhang NN, Shen SH, Jiang LJ, et al. RIG-I plays a critical role in negatively regulating granulocytic proliferation[J]. Proc Natl Acad Sci U S A,2008,105(30):10553-8.
[12] Jiang LJ, Zhang NN, Ding F, et al. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation[J]. Proc Natl Acad Sci U S A,2011,108(5):1897-902.
[13] Boelens MC, Wu TJ, Nabet BY, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways[J]. Cell,2014,159(3):499-513.
[14] Hou J, Zhou Y, Zheng Y, et al. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma[J]. Cancer Cell, 2014,25(1):49-63.
[15] Karlsen TA, Brinchmann JE. Liposome delivery of microRNA-145 to mesenchymal stem cells leads to immunological off-target effects mediated by RIG-I[J]. Mol Ther,2013,21(6):1169-81.